Company Filing History:
Years Active: 2008-2012
Title: Rainer Christine: Innovator in Biotechnological Advancements
Introduction
Rainer Christine is a notable inventor based in Kö'ln, Germany. He has made significant contributions to the field of biotechnology, particularly in the area of gene therapy and cell transfection. With a total of three patents to his name, Rainer has developed innovative solutions that enhance the delivery of biologically active molecules into cells.
Latest Patents
Rainer's latest patents include a circuit arrangement for injecting nucleic acids and other biologically active molecules into the nucleus of higher eukaryotic cells using electrical current. This invention relates to a novel circuit arrangement for electrotransfection or electrofusion, which enables the transportation of DNA and/or other biologically active molecules to the nucleus of higher eukaryotic cells or the fusion of cells, independent of cell division and with reduced cell mortality. Another significant patent is for modular transfection systems, which involves a method for transfection of cells using at least one protein capable of forming nucleoprotein filaments. This method modifies the protein with functional components that influence transfection steps, ultimately leading to the formation of a filament-like complex that is added to the cells for transfection.
Career Highlights
Throughout his career, Rainer has worked with prominent companies such as Lonza Cologne GmbH and Amaxa AG. His work in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in biotechnology.
Collaborations
Rainer has collaborated with notable colleagues, including Gudula Riemen and Ludger Altrogge. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field.
Conclusion
Rainer Christine's contributions to biotechnology through his patents and collaborations highlight his role as an innovator in the field. His work continues to influence advancements in gene therapy and cell transfection, showcasing the importance of innovation in scientific research.